KA
Kevin Ali
Chief Executive OfficerDirector

Kevin Ali insider trades: Organon (OGN) stock purchases

Chief Executive Officer, Organon Last trade May 5, 2025 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
1
Open-market trades
since 2025
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

1 trade reported on SEC Form 4, newest first

DateStockTypeValue
May 5, 2025OGN↑ Buy$299K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OGN insiders

Open-market trades in the last 12 months

About Kevin Ali's insider trades

Kevin Ali is Chief Executive Officer at Organon (OGN). Since May 5, 2025, Kevin has reported 1 open-market purchase worth $299K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (13 filings), option exercises (11 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.